Clinical trial

A Phase I Study of TRN501 in Healthy Volunteers

NCT06453551

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2024-05-10

PhasePHASE1

Study timeline

Study start (actual)2024-05-10Date precision: day

Registry last updated2025-02-07

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Parkinson Diseaseunresolved

Interventions

TRN501 - Dose 1DRUG

TRN501 - Dose 2DRUG

TRN501 - Dose 3DRUG

TRN501 - Dose 4DRUG

TRN501 - Dose 5DRUG

TRN501 - Dose 6DRUG

TRN501 - Dose 7DRUG

TRN501 - Dose 8DRUG

Sponsors & collaborators

SNLD, Ltd.lead sponsor

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT06453551 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.